Tioma Therapeutics Announces $86 Million Series A Financing
August 16, 2016 08:00 ET
|
Vasculox/Tioma Therapeutics
ST. LOUIS, MO and BRISBANE, CA--(Marketwired - Aug 16, 2016) - Tioma Therapeutics, Inc., a venture-stage biopharmaceutical company developing anti-CD47 antibodies for the treatment of solid and...